Download Breakthroughs in Chikungunya research from A*STAR spell new

Breakthroughs in Chikungunya research from A*STAR spell new hope f...
1 of 3
http://www.sciencecodex.com/breakthroughs_in_chikungunya_research_...
RSS Feeds »
Home
Earth
Heavens
Body
Brain
Culture
Tech
Breakthroughs in Chikungunya research from A*STAR spell new hope
for better treatment and protection
posted on: march 14, 2012 - 2:00pm
Tweet
Like
Recent breakthroughs in Chikungunya research spearheaded by scientists at A*STAR's Singapore
Immunology Network (SIgN) have made great strides in the battle against the infectious disease. Working
in close collaborations with Singapore clinician-scientists and international researchers , Dr Lisa Ng,
Principal Investigator of the Chikungunya research group at SIgN, led the team to discover a direct
biomarker which serves as an early and accurate prognosis of patients who have a higher risk of the more
severe form of Chikungunya fever (CHIKF). This means that doctors can now quickly and accurately
identify patients at risk, facilitating a more targetted treatment and clinical care at the onset of the disease.
Chikungunya fever, caused by the Chikungunya virus (CHIKV) , is a mosquito-borne, infectious disease
endemic to Southeast Asia and Africa. Since its re-emergence in 2005, CHIKV infection has spread to nearly
20 countries to infect millions . Singapore, for instance, was hit twice by Chikungunya fever outbreaks in
January and August 2008.
CHIKV infection is characterised by an abrupt onset of fever frequently accompanied by severe muscle and
joint pains. Though most patients recover fully within a week, in severe cases, the joint pains may persist for
months, or even years. For individuals with a weak immune system, the disease can result in death. With no
clinically-approved vaccine or treatment for Chikungunya fever, it remains a worrying public health
problem.
To devise strategies to stop CHIKV transmission, Dr Ng's team collaborated with Professor Leo Yee Sin and
Dr Angela Chow, clinician-scientists from the Communicable Disease Centre (CDC) at Tan Tock Seng
Hospital , to study how the human body responds to CHIKV infection. The team conducted a
comprehensive study on the antibody response against CHIKV in patients. They discovered that patients
who respond to the disease at the onset with high levels of Immunoglobulin G3 (IgG3), a naturally-acquired
antibody, are protected from the more severe form of Chikungunya fever, characterised by persistent joint
pains. On the other hand, patients with a delayed IgG3 response generally have less acute symptoms at the
start, but are more susceptible to chronic debilitating joint pains at later stage of the disease. Hence, the
IgG3 antibodies serve as a specific biomarker of patients with increased risk of the severe form of the
disease.
Collaborating with computational experts from A*STAR's Institute for Infocomm Research (I2R), Dr Ng's
team also uncovered that a very small defined segment of the Chikungunya viral protein, named "E2EP3",
was able to induce the natural IgG3 protective response in preclinical models. They found that mice
vaccinated with the E2EP3 peptides were protected against CHIKV with significant reduction in viral counts
and joint inflammation. This finding raises hope for a new effective Chikungunya vaccine that can offer
protection against Chikungunya virus in the event of an outbreak.
Dr Ng said, "Long-term treatment required for the chronic joint pain in Chikungunya-infected patients
places social and economic burden for both patients and the public healthcare system. We are excited that
the mechanistic insights gained through our collaborative research with the local hospitals and
international research partners have led to discovery of 'new weapons' to tackle Chikungunya more
effectively."
Similar Articles On This Topic:
Potential treatment for Chikungunya
discovered by Vivalis and A*STAR's SIgN
Fruit flies light the way for A*STAR scientists
to pinpoint genetic changes that spell cancer
New research uncovers how to better protect
your smart phone from smudges
Virus-like particle vaccine protects monkeys
from chikungunya virus
13 new technologies in computer graphics and
interactive techniques showcased by
Singapore's A*STAR
Popular Today:
Castles in the desert - satellites reveal lost
cities of Libya
fMRI special section of Perspectives on
Psychological Science
NASA sees twin typhoons headed for double
China landfall
Brain imaging can predict how intelligent you
are, study finds
UCSB autism researchers find that focusing
on strengths improves social skills of
adolescents
Scientific Director of SIgN, Professor Paola Castagnoli said, "With increasing threat of Chikungunya virus
infection, particularly in Asia and the Pacific region, this significant breakthrough is a step forward in
enhancing our pandemic preparedness against the infectious disease. This is a testament to the successful
collaborations between research scientists and clinicians in translating scientific discoveries into impactful
healthcare solutions for the benefit of Singapore and beyond. "
Source: Agency for Science, Technology and Research (A*STAR), Singapore
Post new comment
Your name: *
E-mail: *
The content of this field is kept private and will not be shown publicly.
Homepage:
Comment: *
02-Aug-12 3:38 PM
Breakthroughs in Chikungunya research from A*STAR spell new hope f...
2 of 3
http://www.sciencecodex.com/breakthroughs_in_chikungunya_research_...
Rebellious Kids Correlated To More
Drug Addiction
It Worked! US Energy Emissions Back
At 1992 Levels
The Great Pyramid - Did It Have An
Elevator?
Methanogens: Microbes Make
Eco-Friendly Methane
Constellation Eridanus And NGC 1187:
A Blue Whirlpool In The River
Allowed HTML tags: <em> <strong> <cite><p><br><i><b><center><ul><li><div><html5:figure>
<html5:figcaption>
Lines and paragraphs break automatically.
More information about formatting options
CAPTCHA
Sorry, we know you're not a spambot, but they're out there
Type the two words:
Recent Articles:
Google it?: Internet searches often provide
inaccurate information about infant sleep
safety
HCOs find risks & opportunities in quest for
reduced costs & improved quality
Neutron scattering explains how myoglobin
can perform without water
New chemical sensor makes finding
landmines and buried IEDs easier
Lack of nationwide surveillance may lead to
clusters of congenital anomalies going
unnoticed
more
Read Us On Your Kindle:
02-Aug-12 3:38 PM
Breakthroughs in Chikungunya research from A*STAR spell new hope f...
3 of 3
http://www.sciencecodex.com/breakthroughs_in_chikungunya_research_...
Create Your Own Releases:
Bobby Jindal's Science Problem
Chemistry Sets Used to Be Fun
Drink Wine? Thank a Wasp
Why Toilets Made of Porcelain
We allow third-party companies to serve ads and/or collect anonymous information. These companies may use non-personally identifiable information (browser type,
time and date) in order to provide advertisements about goods and services likely to be of greater interest to you. These companies typically use a cookie or third party
web beacon to collect this information. To learn more about this behavioral advertising practice or to opt-out of this type of advertising, please visit
networkadvertising.org.
02-Aug-12 3:38 PM